When the pancreas can no longer produce enough insulin to compensate for the reduced effectiveness of insulin, blood sugar levels continue to rise, eventually leading to diabetes
For example, some individuals explore tesofensine in conjunction with tirzepatide, yet this requires close medical supervision
Glucagon and GLP- 1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
After 52 weeks, those who remained on the maximum dose maintained a total weight change of -21.9% from their starting weight
90 mg: -1.02%, p=0.001), BW (45 mg: -3.51%, p=0.0019
And though overeating is often unintentional, it can occur easily with a snack here and there